{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:49:47Z","timestamp":1785829787798,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Science Foundation of China","award":["Grant Nos. 81773509"],"award-info":[{"award-number":["Grant Nos. 81773509"]}]},{"name":"a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in China","award":["a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in China"],"award-info":[{"award-number":["a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in China"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02765-7","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:39:02Z","timestamp":1785829142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted metabolomics identifies associations of plasma ceramides and their ratios with incident type 2 diabetes mellitus"],"prefix":"10.1007","author":[{"given":"Chuyi","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-0202","authenticated-orcid":false,"given":"Shaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2765_CR1","doi-asserted-by":"publisher","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","volume":"160","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhou XD, Shapiro MD, Lip GYH, Tilg H, Valenti L et al (2024) Global burden of metabolic diseases, 1990\u20132021. Metabolism 160:155999","journal-title":"Metabolism"},{"key":"2765_CR2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB et al (2022) IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2765_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1042\/EBC20190091","volume":"64","author":"A Gomez-Larrauri","year":"2020","unstructured":"Gomez-Larrauri A, Presa N, Dominguez-Herrera A, Ouro A, Trueba M, Gomez-Mu\u00f1oz A (2020) Role of bioactive sphingolipids in physiology and pathology. Essays Biochem 64(3):579\u2013589","journal-title":"Essays Biochem"},{"issue":"12","key":"2765_CR4","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/clinchem\/hvac158","volume":"68","author":"TT Katajam\u00e4ki","year":"2022","unstructured":"Katajam\u00e4ki TT, Koivula MK, Hilvo M, L\u00e4\u00e4peri MTA, Salminen MJ, Viljanen AM et al (2022) Ceramides and phosphatidylcholines associate with cardiovascular diseases in the elderly. Clin Chem 68(12):1502\u20131508","journal-title":"Clin Chem"},{"key":"2765_CR5","doi-asserted-by":"crossref","unstructured":"Dagogo-Jack S, Asuzu P, Wan J, Grambergs R, Stentz F, Mandal N (2024) Plasma ceramides and other sphingolipids in relation to incident prediabetes in a longitudinal biracial cohort. J Clin Endocrinol Metab 109(10):2530\u20132540","DOI":"10.1210\/clinem\/dgae179"},{"issue":"4","key":"2765_CR6","doi-asserted-by":"publisher","first-page":"e26326","DOI":"10.1016\/j.heliyon.2024.e26326","volume":"10","author":"X Zhong","year":"2024","unstructured":"Zhong X, Xiao C, Wang R, Deng Y, Du T, Li W et al (2024) Lipidomics based on UHPLC\/Q-TOF-MS to characterize lipid metabolic profiling in patients with newly diagnosed type 2 diabetes mellitus with dyslipidemia. Heliyon 10(4):e26326","journal-title":"Heliyon"},{"key":"2765_CR7","doi-asserted-by":"publisher","first-page":"100119","DOI":"10.1016\/j.jlr.2021.100119","volume":"62","author":"AM Fretts","year":"2021","unstructured":"Fretts AM, Jensen PN, Hoofnagle AN, McKnight B, Howard BV, Umans J et al (2021) Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes. J Lipid Res 62:100119","journal-title":"J Lipid Res"},{"issue":"5","key":"2765_CR8","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/jn\/nxz259","volume":"150","author":"AM Fretts","year":"2020","unstructured":"Fretts AM, Jensen PN, Hoofnagle A, McKnight B, Howard BV, Umans J et al (2020) Plasma ceramide species are associated with diabetes risk in participants of the strong heart study. J Nutr 150(5):1214\u20131222","journal-title":"J Nutr"},{"issue":"3","key":"2765_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.numecd.2023.10.026","volume":"34","author":"JC Bae","year":"2024","unstructured":"Bae JC, Wander PL, Lemaitre RN, Fretts AM, Sitlani CM, Bui HH et al (2024) Associations of plasma sphingolipids with measures of insulin sensitivity, \u03b2-cell function, and incident diabetes in Japanese Americans. Nutr Metab Cardiovasc Dis 34(3):633\u2013641","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"2765_CR10","doi-asserted-by":"publisher","first-page":"e1003451","DOI":"10.1371\/journal.pmed.1003451","volume":"17","author":"H Yun","year":"2020","unstructured":"Yun H, Sun L, Wu Q, Zong G, Qi Q, Li H et al (2020) Associations among circulating sphingolipids, \u03b2-cell function, and risk of developing type 2 diabetes: a population-based cohort study in China. PLoS Med 17(12):e1003451","journal-title":"PLoS Med"},{"issue":"12","key":"2765_CR11","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1007\/s00125-018-4720-1","volume":"61","author":"IJ Neeland","year":"2018","unstructured":"Neeland IJ, Singh S, McGuire DK, Vega GL, Roddy T, Reilly DF et al (2018) Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia 61(12):2570\u20132579","journal-title":"Diabetologia"},{"issue":"8","key":"2765_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00018-022-04401-3","volume":"79","author":"P Hammerschmidt","year":"2022","unstructured":"Hammerschmidt P, Br\u00fcning JC (2022) Contribution of specific ceramides to obesity-associated metabolic diseases. Cell Mol Life Sci 79(8):395","journal-title":"Cell Mol Life Sci"},{"key":"2765_CR13","doi-asserted-by":"crossref","unstructured":"Shao F, Hu X, Li J, Bai B, Tian L (2023) Lipidomics analysis of impaired glucose tolerance and type 2 diabetes mellitus in overweight or obese elderly adults. Endocr Connect 12(12):e230212","DOI":"10.1530\/EC-23-0212"},{"key":"2765_CR14","doi-asserted-by":"publisher","first-page":"570628","DOI":"10.3389\/fendo.2020.570628","volume":"11","author":"M Hilvo","year":"2020","unstructured":"Hilvo M, Vasile VC, Donato LJ, Hurme R, Laaksonen R (2020) Ceramides and ceramide scores: clinical applications for cardiometabolic risk stratification. Front Endocrinol 11:570628","journal-title":"Front Endocrinol"},{"key":"2765_CR15","doi-asserted-by":"crossref","unstructured":"Gaggini M, Michelucci E, Ndreu R, Rocchiccioli S, Chatzianagnostou K, Berti S et al (2023) Lipidomic analysis to assess the correlation between ceramides, stress hyperglycemia, and HbA1c in acute myocardial infarction. Molecules 28(2):716","DOI":"10.3390\/molecules28020716"},{"issue":"25","key":"2765_CR16","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D et al (2016) Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J 37(25):1967\u20131976","journal-title":"Eur Heart J"},{"issue":"6","key":"2765_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.5603\/PJNNS.a2019.0063","volume":"53","author":"A Fiedorowicz","year":"2019","unstructured":"Fiedorowicz A, Kozak-Syka\u0142a A, Bobak \u0141, Ka\u0142as W, Strz\u0105da\u0142a L (2019) Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke. Neurol Neurochir Pol 53(6):484\u2013491","journal-title":"Neurol Neurochir Pol"},{"key":"2765_CR18","doi-asserted-by":"crossref","unstructured":"Peterson LR, Xanthakis V, Duncan MS, Gross S, Friedrich N, V\u00f6lzke H et al (2018) Ceramide remodeling and risk of cardiovascular events and mortality. J Am Heart Assoc 7(10):e007931","DOI":"10.1161\/JAHA.117.007931"},{"key":"2765_CR19","doi-asserted-by":"crossref","unstructured":"Michelucci E, Rocchiccioli S, Gaggini M, Ndreu R, Berti S, Vassalle C (2022) Ceramides and cardiovascular risk factors, inflammatory parameters and left ventricular function in AMI patients. Biomedicines 10(2):429","DOI":"10.3390\/biomedicines10020429"},{"issue":"6","key":"2765_CR20","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s00125-018-4590-6","volume":"61","author":"M Hilvo","year":"2018","unstructured":"Hilvo M, Salonurmi T, Havulinna AS, Kauhanen D, Pedersen ER, Tell GS et al (2018) Ceramide stearic to palmitic acid ratio predicts incident diabetes. Diabetologia 61(6):1424\u20131434","journal-title":"Diabetologia"},{"key":"2765_CR21","doi-asserted-by":"publisher","first-page":"108991","DOI":"10.1016\/j.diabres.2021.108991","volume":"179","author":"SB Dugani","year":"2021","unstructured":"Dugani SB, Christenson LR, Aakre JA, Bui HH, Vella A, Mielke MM (2021) Association of plasma ceramides with prevalent and incident type 2 diabetes mellitus in middle and older aged adults. Diabetes Res Clin Pract 179:108991","journal-title":"Diabetes Res Clin Pract"},{"key":"2765_CR22","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3389\/fphys.2020.01104","volume":"11","author":"R Cao","year":"2020","unstructured":"Cao R, Fang Z, Li S, Xu M, Zhang J, Han D et al (2020) Circulating ceramide: a new cardiometabolic biomarker in patients with comorbid acute coronary syndrome and type 2 diabetes Mellitus. Front Physiol 11:1104","journal-title":"Front Physiol"},{"key":"2765_CR23","doi-asserted-by":"publisher","first-page":"23939","DOI":"10.1038\/srep23939","volume":"6","author":"SY Zhang","year":"2016","unstructured":"Zhang SY, Wu JH, Zhou JW, Liang Z, Qiu QY, Xu T et al (2016) Overweight, resting heart rate, and prediabetes\/diabetes: a population-based prospective cohort study among Inner Mongolians in China. Sci Rep 6:23939","journal-title":"Sci Rep"},{"issue":"12","key":"2765_CR24","first-page":"e49774","volume":"15","author":"N Kozhisseri","year":"2023","unstructured":"Kozhisseri N, Rajaram D, Cheluvaraj P (2023) Prevalence of elevated blood pressure and its relationship with anthropometric risk factors in students of a Pre-university Girls\u2019 College in Bangalore: a cross-sectional study. Cureus 15(12):e49774","journal-title":"Cureus"},{"issue":"4","key":"2765_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20(4):470\u2013475","journal-title":"Clin Chem"},{"issue":"6","key":"2765_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"issue":"8","key":"2765_CR27","first-page":"750","volume":"43","author":"G Huang","year":"2021","unstructured":"Huang G, Zhou H, Shen C, Sheng Y, Xue R, Dong C et al (2021) Bi-directional and temporal relationship between elevated alanine aminotransferase and hypertension in a longitudinal study of Chinese adults. Clin Exp Hypertens (New York NY: 1993) 43(8):750\u2013757","journal-title":"Clin Exp Hypertens (New York NY: 1993)"},{"issue":"4","key":"2765_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.2337\/db12-0363","volume":"62","author":"CL Kien","year":"2013","unstructured":"Kien CL, Bunn JY, Poynter ME, Stevens R, Bain J, Ikayeva O et al (2013) A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults. Diabetes 62(4):1054\u20131063","journal-title":"Diabetes"},{"issue":"1","key":"2765_CR29","doi-asserted-by":"publisher","first-page":"100726","DOI":"10.1016\/j.jlr.2024.100726","volume":"66","author":"S Wang","year":"2025","unstructured":"Wang S, Jin Z, Wu B, Morris AJ, Deng P (2025) Role of dietary and nutritional interventions in ceramide-associated diseases. J Lipid Res 66(1):100726","journal-title":"J Lipid Res"},{"issue":"12","key":"2765_CR30","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1210\/jc.2019-00160","volume":"104","author":"F Rosqvist","year":"2019","unstructured":"Rosqvist F, Kullberg J, St\u00e5hlman M, Cedernaes J, Heurling K, Johansson HE et al (2019) Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial. J Clin Endocrinol Metab 104(12):6207\u20136219","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2765_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00011-019-01273-5","volume":"68","author":"J Korbecki","year":"2019","unstructured":"Korbecki J, Bajdak-Rusinek K (2019) The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms. Inflamm Res 68(11):915\u2013932","journal-title":"Inflamm Res"},{"issue":"1","key":"2765_CR32","doi-asserted-by":"publisher","first-page":"e000691","DOI":"10.1136\/bmjdrc-2019-000691","volume":"7","author":"W Qureshi","year":"2019","unstructured":"Qureshi W, Santaren ID, Hanley AJ, Watkins SM, Lorenzo C, Wagenknecht LE (2019) Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS). BMJ Open Diabetes Res Care 7(1):e000691","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"2765_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/MOL.0000000000000806","volume":"33","author":"RN Lemaitre","year":"2022","unstructured":"Lemaitre RN, King IB (2022) Very long-chain saturated fatty acids and diabetes and cardiovascular disease. Curr Opin Lipidol 33(1):76\u201382","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"2765_CR34","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1093\/clinchem\/hvab182","volume":"67","author":"AM Fretts","year":"2021","unstructured":"Fretts AM, Jensen PN, Hoofnagle AN, McKnight B, Sitlani CM, Siscovick DS et al (2021) Circulating ceramides and sphingomyelins and risk of mortality: the cardiovascular health study. Clin Chem 67(12):1650\u20131659","journal-title":"Clin Chem"},{"key":"2765_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fendo.2019.00577","volume":"10","author":"E Sokolowska","year":"2019","unstructured":"Sokolowska E, Blachnio-Zabielska A (2019) The role of ceramides in insulin resistance. Front Endocrinol 10:577","journal-title":"Front Endocrinol"},{"issue":"35","key":"2765_CR36","doi-asserted-by":"publisher","first-page":"36608","DOI":"10.1074\/jbc.M406499200","volume":"279","author":"S Stratford","year":"2004","unstructured":"Stratford S, Hoehn KL, Liu F, Summers SA (2004) Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B. J Biol Chem 279(35):36608\u201336615","journal-title":"J Biol Chem"},{"issue":"9","key":"2765_CR37","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.numecd.2024.05.012","volume":"34","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ni Y, An H, Li L, Ren Y (2024) Multidimensional plasma lipid composition and its causal association with type 2 diabetes mellitus: a mendelian randomization study. Nutr Metab Cardiovasc Dis 34(9):2075\u20132084","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2765_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2021.04.021","volume":"327","author":"KA McGurk","year":"2021","unstructured":"McGurk KA, Keavney BD, Nicolaou A (2021) Circulating ceramides as biomarkers of cardiovascular disease: evidence from phenotypic and genomic studies. Atherosclerosis 327:18\u201330","journal-title":"Atherosclerosis"},{"issue":"1","key":"2765_CR39","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/s41467-022-28496-1","volume":"13","author":"C Wittenbecher","year":"2022","unstructured":"Wittenbecher C, Cuadrat R, Johnston L, Eichelmann F, J\u00e4ger S, Kuxhaus O et al (2022) Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology. Nat Commun 13(1):936","journal-title":"Nat Commun"},{"issue":"1","key":"2765_CR40","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1038\/s41467-018-05613-7","volume":"9","author":"N Turner","year":"2018","unstructured":"Turner N, Lim XY, Toop HD, Osborne B, Brandon AE, Taylor EN et al (2018) A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism. Nat Commun 9(1):3165","journal-title":"Nat Commun"},{"issue":"2","key":"2765_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrendo.2016.169","volume":"13","author":"PJ Meikle","year":"2017","unstructured":"Meikle PJ, Summers SA (2017) Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat reviews Endocrinol 13(2):79\u201391","journal-title":"Nat reviews Endocrinol"},{"issue":"3","key":"2765_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.12997\/jla.2021.10.3.268","volume":"10","author":"ID Zelnik","year":"2021","unstructured":"Zelnik ID, Kim JL, Futerman AH (2021) The complex tail of circulating sphingolipids in atherosclerosis and cardiovascular disease. J Lipid Atheroscler 10(3):268\u2013281","journal-title":"J Lipid Atheroscler"},{"issue":"3","key":"2765_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1124\/molpharm.123.000788","volume":"105","author":"WJ Richardson","year":"2024","unstructured":"Richardson WJ, Humphrey SB, Sears SM, Hoffman NA, Orwick AJ, Doll MA et al (2024) Expression of ceramide synthases in mice and their roles in regulating acyl-chain sphingolipids: a framework for baseline levels and future implications in aging and disease. Mol Pharmacol 105(3):131\u2013143","journal-title":"Mol Pharmacol"},{"key":"2765_CR44","doi-asserted-by":"crossref","unstructured":"Shoghli M, Lokki AI, L\u00e4\u00e4peri M, Sinisalo J, Lokki ML, Hilvo M et al (2023) The novel ceramide- and phosphatidylcholine-based risk score for the prediction of new-onset of hypertension. J Clin Med 12(24):7524","DOI":"10.3390\/jcm12247524"},{"issue":"2","key":"2765_CR45","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cmet.2017.12.003","volume":"27","author":"SA Summers","year":"2018","unstructured":"Summers SA (2018) Could ceramides become the new cholesterol? Cell Metab 27(2):276\u2013280","journal-title":"Cell Metab"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02765-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02765-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02765-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:39:11Z","timestamp":1785829151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02765-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":45,"alternative-id":["2765"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02765-7","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No potential conflict of interest relevant to this article was reported.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Boards of Soochow University and the Suzhou Industrial Park Centers for Disease Control and Prevention (Approval No. SIPCDC-EA-2020002-01). All participants provided informed consent.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}